Clinical Trial Update: Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of fluorouracil, irinotecan, leucovorin, and cisplatin as first-line therapy for metastatic esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• FLUOROURACIL (Fluorouracil)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN